EP3829761A1 - Verfahren zur herstellung eines adsorbens für phosphat in wässrigem medium - Google Patents
Verfahren zur herstellung eines adsorbens für phosphat in wässrigem mediumInfo
- Publication number
- EP3829761A1 EP3829761A1 EP19742785.9A EP19742785A EP3829761A1 EP 3829761 A1 EP3829761 A1 EP 3829761A1 EP 19742785 A EP19742785 A EP 19742785A EP 3829761 A1 EP3829761 A1 EP 3829761A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- suspension
- iron
- oxy
- hydroxide
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910019142 PO4 Inorganic materials 0.000 title claims abstract description 33
- 239000010452 phosphate Substances 0.000 title claims abstract description 32
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 title claims abstract description 31
- 239000003463 adsorbent Substances 0.000 title claims abstract description 13
- 239000012736 aqueous medium Substances 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title description 6
- 238000000034 method Methods 0.000 claims abstract description 69
- 238000009295 crossflow filtration Methods 0.000 claims abstract description 22
- 239000012466 permeate Substances 0.000 claims abstract description 19
- 238000001914 filtration Methods 0.000 claims abstract description 15
- 239000000470 constituent Substances 0.000 claims abstract description 12
- 239000012465 retentate Substances 0.000 claims abstract description 11
- 230000032683 aging Effects 0.000 claims abstract description 10
- 239000000725 suspension Substances 0.000 claims description 78
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 68
- 239000012528 membrane Substances 0.000 claims description 50
- 238000003756 stirring Methods 0.000 claims description 35
- 239000008367 deionised water Substances 0.000 claims description 30
- 229910021641 deionized water Inorganic materials 0.000 claims description 30
- MSNWSDPPULHLDL-UHFFFAOYSA-K ferric hydroxide Chemical compound [OH-].[OH-].[OH-].[Fe+3] MSNWSDPPULHLDL-UHFFFAOYSA-K 0.000 claims description 28
- 229910052742 iron Inorganic materials 0.000 claims description 28
- 229910021519 iron(III) oxide-hydroxide Inorganic materials 0.000 claims description 22
- CUPCBVUMRUSXIU-UHFFFAOYSA-N [Fe].OOO Chemical compound [Fe].OOO CUPCBVUMRUSXIU-UHFFFAOYSA-N 0.000 claims description 19
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 16
- 150000001720 carbohydrates Chemical class 0.000 claims description 15
- 235000014633 carbohydrates Nutrition 0.000 claims description 15
- 239000002585 base Substances 0.000 claims description 13
- 239000000919 ceramic Substances 0.000 claims description 12
- 239000007864 aqueous solution Substances 0.000 claims description 9
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 claims description 8
- 239000004021 humic acid Substances 0.000 claims description 8
- 239000011148 porous material Substances 0.000 claims description 8
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 6
- 230000002452 interceptive effect Effects 0.000 claims description 6
- 150000001339 alkali metal compounds Chemical class 0.000 claims description 5
- 150000002500 ions Chemical class 0.000 claims description 5
- 238000010924 continuous production Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000007900 aqueous suspension Substances 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 abstract description 11
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 abstract description 3
- 238000000926 separation method Methods 0.000 abstract description 3
- 239000011541 reaction mixture Substances 0.000 description 50
- 239000000243 solution Substances 0.000 description 46
- 235000021317 phosphate Nutrition 0.000 description 30
- 238000012546 transfer Methods 0.000 description 17
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 15
- 238000010908 decantation Methods 0.000 description 14
- 238000003926 complexometric titration Methods 0.000 description 13
- 239000006228 supernatant Substances 0.000 description 13
- 102000006335 Phosphate-Binding Proteins Human genes 0.000 description 12
- 108010058514 Phosphate-Binding Proteins Proteins 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 229920002472 Starch Polymers 0.000 description 11
- 229930006000 Sucrose Natural products 0.000 description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 11
- 239000008107 starch Substances 0.000 description 11
- 235000019698 starch Nutrition 0.000 description 11
- 229960004793 sucrose Drugs 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical group [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000005720 sucrose Substances 0.000 description 10
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 description 8
- 229910002588 FeOOH Inorganic materials 0.000 description 7
- 238000002798 spectrophotometry method Methods 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 229920001592 potato starch Polymers 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000011550 stock solution Substances 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000010907 mechanical stirring Methods 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 238000001179 sorption measurement Methods 0.000 description 5
- 229960004158 sucroferric oxyhydroxide Drugs 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 229910010293 ceramic material Inorganic materials 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000001694 spray drying Methods 0.000 description 3
- 229940078826 velphoro Drugs 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000001631 haemodialysis Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 150000002506 iron compounds Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 101100168115 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) con-6 gene Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FQIOHYRHRMILMJ-UHFFFAOYSA-N [Fe+3].OOO Chemical class [Fe+3].OOO FQIOHYRHRMILMJ-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 1
- 239000011609 ammonium molybdate Substances 0.000 description 1
- 235000018660 ammonium molybdate Nutrition 0.000 description 1
- 229940010552 ammonium molybdate Drugs 0.000 description 1
- 239000012378 ammonium molybdate tetrahydrate Substances 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 239000012935 ammoniumperoxodisulfate Substances 0.000 description 1
- FIXLYHHVMHXSCP-UHFFFAOYSA-H azane;dihydroxy(dioxo)molybdenum;trioxomolybdenum;tetrahydrate Chemical compound N.N.N.N.N.N.O.O.O.O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O[Mo](O)(=O)=O.O[Mo](O)(=O)=O.O[Mo](O)(=O)=O FIXLYHHVMHXSCP-UHFFFAOYSA-H 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000020805 dietary restrictions Nutrition 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 201000005991 hyperphosphatemia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000014413 iron hydroxide Nutrition 0.000 description 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- -1 metal oxide oxy-hydroxides Chemical class 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002694 phosphate binding agent Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
- B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/16—Feed pretreatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3085—Chemical treatments not covered by groups B01J20/3007 - B01J20/3078
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/18—Details relating to membrane separation process operations and control pH control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/24—Quality control
- B01D2311/243—Electrical conductivity control
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2311/00—Details relating to membrane separation process operations and control
- B01D2311/25—Recirculation, recycling or bypass, e.g. recirculation of concentrate into the feed
- B01D2311/252—Recirculation of concentrate
- B01D2311/2523—Recirculation of concentrate to feed side
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2315/00—Details relating to the membrane module operation
- B01D2315/16—Diafiltration
Definitions
- This invention relates to a process for preparing an adsorbent for phosphate comprising stabilized iron oxy-hydroxide in aqueous medium at industrial scale.
- WO9201458A1 discloses a method of controlling serum phosphate levels in patients by use of phosphate adsorbers based on iron oxy-hydroxides which bind to ingested phosphate.
- Sucroferric oxy-hydroxide (INN; trade name Velphoro, by Vifor Fresenius Medical Care Renal Pharma) is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adult patients with chronic kidney disease on haemodialysis or peritoneal dialysis.
- Sucroferric oxy-hydroxide is a complex which consist of polynuclear iron (III) oxy-hydroxide (pn-FeOOH), sucrose, and starch.
- the pn-FeOOH moiety is chemically not stable and cannot be isolated and stored as an active pharmaceutical ingredient.
- the sucrose and the starch are also necessary for the processability of the active substance during the manufacturing process of the finished product (cf. Chemical review for Velphoro of the FDA, page 8 or Assessment Report of the EMA, page 12).
- Sucroferric oxy-hydroxide was first described in the patent family of US6174442B1 (EP0868125B1 ).
- This patent describes polynuclear beta-iron hydroxide stabilized by carbohydrates and/or humic acid.
- the product was prepared by reacting, in a first step, an aqueous solution of iron (III) chloride with an aqueous solution of a base which produced a suspension of polynuclear iron (III) oxy-hydroxide (pn-FeOOH).
- the resulting suspension was washed with water to remove interfering anions, such as chloride ions.
- the carbohydrate or humic acid was added to the suspension before the resulting beta-iron oxy-hydroxide ages.
- W02009/062993A1 relates to pharmaceutical compositions comprising stabilized iron (III) oxy-hydroxide compounds.
- Example 1 a premixture of the stabilized iron (III) oxy- hydroxide was obtained by mixing amounts/ratios of an iron oxy-hydroxide suspension prepared according to EP0868125B1 with several excipients. The suspension was subjected to spray drying at 135-200 °C to obtain a flowable powder.
- W02008/071747A1 discloses a process for preparing iron (lll)-based phosphate adsorbent comprising iron (III) oxy-hydroxide, insoluble carbohydrate, such as starch; and soluble carbohydrate, such as sucrose.
- the reaction between an aqueous solution of iron (III) salt and an aqueous base is performed in the presence of starch.
- a precipitate containing iron (III) oxy-hydroxide and starch is isolated and washed three times with water using a decanter centrifuge
- the resulting iron oxy-hydroxide may be stabilized by adding the soluble carbohydrate to the precipitate before the iron hydroxide ages.
- the inventors have found a dynamic process based on the use of tangential-flow filtration to desalinate and concentrate the suspension of precipitated polynuclear iron (III) oxy- hydroxide, that allows reducing considerably the production times, avoids product loss, and maintain the stability and the phosphate binding capacity of the polynuclear iron (III)- oxy-hydroxide when the product is produced at industrial scale.
- the most common uses of tangential-flow filtration are water treatments and purifications of biomolecules where the permeate is of most value.
- tubular filtration membranes can be effectively used to desalinate the suspension of polynuclear iron (III) oxy-hydroxide by tangential-flow filtration is unexpected since one skilled in the art would have expected that the fine particles of the precipitated polynuclear iron (III) oxy-hydroxide had settled out in the membrane. He would have also expected that the use of a dynamic system that requires a huge amount of energy had produced the degradation of the polynuclear iron (III) oxy-hydroxide.
- the process of the present invention is easy to set up and can be easily scaled-up, it is economical since the membranes can be reused, and allows achieving high concentrations in the suspension in less time than when centrifugal devices or static decantation systems are used, without degradation of the product.
- an aspect of the present invention relates to a process for producing an adsorbent for phosphate from aqueous medium comprising polynuclear iron oxy- hydroxide stabilized by at least one constituent that inhibits ageing of the iron oxy- hydroxide, the process comprising the following steps:
- step b) submitting the suspension of precipitated iron (III) oxy-hydroxide of step a) to a desalinization process through tangential-flow filtration which comprises the steps of: b1 ) pumping the suspension to a tubular filtration membrane which is connected to the feed reservoir to flow parallel to the membrane face, thereby interfering ions are removed from the suspension with the permeate;
- step b) contacting the resulting aqueous suspension of step b) with at least one constituent that inhibits ageing of the iron oxy-hydroxide selected from the group consisting of one or more carbohydrates and/or humic acid; and
- interfering ions refers to the chloride ions which are the anions of the trivalent iron compound used as starting material.
- cross-flow filtration or “tangential-flow filtration” are used interchangeably herein to refer to a separation process that uses a tubular filtration membrane to separate the salts in a liquid on the basis of size and that it is characterized for operation in a recirculation mode where the retentate is returned to the system as feed. It is
- the permeate is recovered from the system in a container and the retentate is recirculated to the feed tank. Recirculation of the retentate improves salt separation effectiveness.
- feed or “feed flow” or “feed stream” refer to the suspension comprising polynuclear iron oxy-hydroxide that is delivered to the tubular filtration membrane.
- permeate refers to the portion of the feed that has permeated through the membrane.
- retentate refers to the suspension that has been retained by the membrane and is enriched in a retained species.
- microfiltration membrane is used herein to refer to a membrane that has average diameter pore size in the range of about 0.1 pm to 0.65 pm.
- pressure inlet is used here to refer to the feed pressure on inlet side of membrane.
- Pressure outlet is the feed pressure on outlet side of membrane.
- Permeate pressure is the permeate pressure on outlet side of membrane.
- the process according to the invention allows producing an adsorbent for adsorbing phosphate from aqueous medium comprising polynuclear iron (III) oxy-hydroxide stabilized by at least one constituent that inhibits ageing of the iron oxy-hydroxide. It comprises several steps disclosed in detail below.
- the polynuclear iron oxy-hydroxide is polynuclear beta-iron oxy-hydroxide.
- the process comprises reacting in a feed reservoir a base, which is an alkali metal compound, with iron (III) chloride in water to yield a suspension of a pH of at least 3 of precipitated iron (III) oxy-hydroxide comprising from 50 to 120 L of water per Kg of Fe (FeC ).
- the reaction product is an iron oxy-hydroxide in colloidal form together with a salt composed of the cation of the base and the anion of the trivalent iron compound.
- this step is carried out at a temperature comprised from 10 to 25 °C.
- the process of the present invention is that which comprises mixing an aqueous solution of a base, which is an alkali metal compound, with an aqueous solution of an iron (III) chloride, to form the suspension of precipitated iron (III) oxy-hydroxide.
- the base is a carbonate or a bicarbonate of an alkali metal such as sodium or potassium.
- the base is selected from sodium carbonate, and sodium bicarbonate.
- the base is used in the form of aqueous solution.
- the pH is comprised from 3 to 10.
- the pH of the reaction mixture is at least about 6.
- the pH is 6.5.
- the amount of base added in step a) is the amount needed to get a pH of at least 3.
- the suspension in step a) may either be allowed to stand or it can be submitted to intervals of stirring. In a particular embodiment, several cycles of stirring/stop/stirring the suspension of precipitated iron (III) oxy-hydroxide are performed, for instance, five cycles in another particular embodiment, the time of each stirring step and of each stop step is 10-15 minutes.
- the suspension of precipitated iron oxy-hydroxide is submitted to a desalinization process through tangential-flow filtration to remove interfering ions such as chloride ions.
- the suspension is maintained under stirring in a feed reservoir at a temperature comprised from 10 to 25 °C to avoid degradation of the product. Preferably, the temperature is from 15 to 25 °C.
- the concentration of iron in the suspension before the desalinization process is 50-120 L of water per Kg of Fe, which corresponds to around 0.5-2% w/w (g Fe per g of suspension) determined by complexometric titration.
- the suspension can be submitted directly to the tangential-flow filtration or it can be first diluted and then submitted to the tangential-flow filtration.
- the concentration of iron in the suspension of step a) is 50 L of water per Kg of Fe (FeC ).
- an amount from 1 to 70 L of water per Kg of Fe is added before the desalinization step.
- an amount from 30 to 70 L of water per Kg of Fe is added before the desalinization step.
- an amount from 50 to 70 L of water per Kg of Fe is added before the desalinization step.
- the tangential-flow filtration in comparison to the dead-end filtration, allows the solids to be kept in suspension and minimizes the build-up of a filter cake to plug or foul the membrane.
- filtration tubular membrane refers to a selectively permeable membrane for separating a feed, into a permeate stream and a retentate stream using a tangential flow filtration process.
- tubular membranes are not self-supporting membranes. They are located on the inside of a tube, made of a special kind of material. This material is the supporting layer for the membrane.
- the filtration tubular membrane may be a polymeric membrane or a ceramic membrane.
- the membrane is a polymeric membrane.
- polymeric membranes are polyvinylidine fluoride (PVDF) and polyether sulfone.
- PVDF polyvinylidine fluoride
- the PVDF is commercialized as DuraponeTM.
- the membrane is a ceramic membrane.
- the ceramic membrane may either have one canal or a plurality of canals. Ceramic membranes have been known for a considerable number of years.
- a ceramic membrane comprises a layer of porous ceramic material with a pore diameter of the required size.
- the average diameter pore is comprised from 0.1 to 0.65 pm. In a particular embodiment the average diameter pore sizes of the membrane is between 0.1 pm and 0.3 pm. In another particular embodiment the average diameter pore is 0.2 pm.
- the membrane area is comprised from 0.07 m 2 to 1.75 m 2 .
- the ceramic column has a diameter of 25 mm and a length 1 178 mm. In another particular embodiment, the ceramic column has 23 canals of 3.5 mm of equivalent diameter.
- the membrane may be supported on a body of coarse pore ceramic material, in particular Zr0 2 -TiC> 2 , and the body and membrane may be sintered together.
- the support body may be an elongate element, and may have a plurality of parallel longitudinal channels each lined with a thin membrane layer of the fine-pore ceramic material.
- the desalinization process through tangential flow filtration comprises a first step b1 ) of pumping the suspension of precipitated iron (III) oxy-hydroxide through a tubular filtration membrane which is connected to the feed reservoir, to flow parallel to the membrane face, thereby interfering ions are removed from the suspension with the permeate which passes through the membrane walls.
- the remainder suspension is flowed back to the feed reservoir (step b2).
- the concentration of the iron (III) oxy-hydroxide in the suspension increases when eliminating the permeate through the membrane.
- fresh deionized water is added to the feed reservoir to continue washing the iron oxy-hydroxide
- the process of the present invention is that which comprises adding an amount of 230 to 460 L of water per Kg of Fe during the desalinization process.
- the conductivity of the resulting suspension is equal to or less than 3.5 mS. In a particular embodiment, the conductivity of the resulting suspension is equal to or less than 2 mS.
- step b4) is recirculated to reduce the volume of the suspension;
- the process according to the invention further comprises reciculating the retentate obtained in step b4) until reaching a volume of 15 to 25 L per Kg of Fe in the feed reservoir.
- the tangential-flow filtration process is carried out at a pressure inlet comprised from 100 to 300 KPa (1- 3 bars), preferably 200 KPa (2.0 bar) and a pressure outlet comprised from 50 to 200 KPa (0.5 to 2 bars), preferably, 150 KPa (1.5 bar).
- the permeate pressure is comprised from 75 to 150 KPa (0.75 to 1.5 bars), preferably 20-30 KPa (0.2-0.3 bars), more preferably, 30 KPa (0.3 bars).
- the tangential-flow filtration is carried out at a temperature comprised from 15 to 25 °C.
- the filtration is carried out in discontinuous, the suspension is first diluted and then concentrated back to the starting volume. This process is then repeated until the required concentration of salts remaining in the reservoir is reached.
- the filtration is a continuous process.
- the continuous process is advantageous since it requires less filtrate volume to achieve the same degree of salt reduction as discontinuous tangential flow filtration. This represents a substantial saving in time.
- both the discontinuous and the continuous process of desalinization of the present invention are carried out in a short time at industrial scale (150 Kg), generally it it takes about 24 hours.
- the iron content of the suspension obtained is up to 6% w/w, preferably 2 to 6% w/w, most preferably, around 2-4% w/w (g Fe per g of suspension). In a particular embodiment, around 5.2% w/w of Fe.
- the pH of the suspension is generally in the range of approximately 6.5 to 7.5 before further constituents are added.
- the subsequent step comprises contacting the resulting aqueous suspension of step b) with at least one constituent that inhibits ageing of the iron oxy-hydroxide.
- the at least one constituent that inhibits ageing of the iron oxy-hydroxide is selected from the group consisting of one or more carbohydrates and/or humic acid.
- the constituent that inhibits ageing of the iron oxy- hydroxide is a carbohydrate selected from the group consisting of starch, sucrose, and mixtures thereof.
- the constituent is preferably added in solid form.
- the amount of carbohydrates or humic acid is preferably selected so that at least 0.5 g carbohydrate or humic acid are added per g of iron (calculated as Fe).
- the maximum content of carbohydrates and/or humic acid is not subject to any limits.
- the content of carbohydrates is from 5 to 60% by weight (w/w).
- Soluble carbohydrates can be used such as sugars, e.g. agarose, dextran, dextrin, dextran derivatives, cellulose and cellulose derivatives, saccharose, maltose, lactose, or mannitol.
- the carbohydrate is starch, sucrose, dextrin, starch, or mixtures thereof.
- starch as used herein includes any conventionally used starch products (such as potato starch, corn starch, rice starch, tapioca starch) in native, pregelatinized, degraded, modified and derivatized forms.
- the process comprises a step d) which comprises drying the suspension thus obtained.
- the drying can be carried out, for example, by concentration in vacuum or by spray drying.
- the maximum iron content in the final product is around 40% w/w. In a particular embodiment the iron content is at least 20% w/w.
- the iron content is given, it has been determined by complexometric titration following the method included in the Examples.
- the polynuclear beta-iron oxy-hydroxide adsorbent obtained following the process of the present invention shows a good phosphate-binding capacity equal to the adsorbent obtained by the process using static washing instead of tangential-flow filtration at small scale, which evidence that following the process of the present invention, the product does not suffer more degradation when it is prepared at industrial scale.
- the phosphate binding capacity is determined by spectrophotometric analysis as illustrated in the
- the phosphate adsorbent of the present invention provides a phosphate binding capacity of at least 0.21 mgP/mgFe.
- the phosphate binding capacity is equal to or higher than 0.23 mgP/mgFe.
- the preparation process according to the invention allows obtaining a phosphate adsorbent for adsorbing phosphate from aqueous medium comprising polynuclear beta- iron oxy-hydroxide stabilized by at least one constituent that inhibits ageing of the iron oxy-hydroxide.
- the adsorbents thus obtained are suitable for the adsorption of phosphates from aqueous solutions, for example, for the adsorption of inorganic phosphate and phosphate bonded to foodstuffs from body fluids, chyme and foodstuffs.
- Diameter 25” - length 1178 mm.
- Iron content (complexometric titration): The method is based on USP ⁇ 541 > and Ph. Eur. (2.2.20).
- Test solution Transfer 1.5 g of the sample, accurately weighed, to a 100 ml. volumetric flask, dissolve with 10 mL of cone. HCI and 10 ml. of water at 45°C, allow the solution to cool at room temperature and dilute to volume with water. Prepare in duplicate.
- Each mL of 0.1 N CuS0 4 is equivalent to 5.58 mg of Iron.
- Phosphate adsorption method of analysis (by spectrophotometric analysis): The method is based on USP ⁇ 851 > / Ph. Eur. (2.2.25).
- Phosphate stock solution Transfer 0.717 g of KhhPCU, accurately weighed, into a 500 mL volumetric flask, dissolve and dilute to volume with water. Transfer 5.0 mL of this solution to a 50 mL volumetric flask and dilute to volume with water.
- Mix solution mix one part of Solution A and six parts of Solution B. Prepare the solution just before use and maintain the solution in an ice bath during the samples preparation.
- 0.65 ppm Phosphorous solution Transfer 1.0 mL of the phosphate stock solution to a 50 mL volumetric flask and dilute to volume with water.
- 1.30 ppm Phosphorous solution Transfer 2.0 ml. of the phosphate stock solution to a 50 ml. volumetric flask and dilute to volume with water.
- 1.96 ppm Phosphorous solution Transfer 3.0 ml. of the phosphate stock solution to a 50 ml. volumetric flask and dilute to volume with water.
- Phosphorous solution Transfer 5.0 ml. of the phosphate stock solution to a 50 ml. volumetric flask and dilute to volume with water.
- 0.16 ppm Phosphorous solution Transfer 5.0 ml. of the 0.65 ppm Phosphorous solution to a 20 mL volumetric flask and dilute to volume with water.
- 0.065 ppm Phosphorous solution Transfer 5.0 mL of the 0.65 ppm Phosphorous solution to a 50 mL volumetric flask and dilute to volume with water.
- Phosphorous spiking solution Transfer 20.52 g of Na3P04-12H20, accurately weighed, to a 1 L volumetric flask, dissolve and dilute to volume with water.
- Test solution Accurately weigh 250.0 mg of sample into a 50 mL centrifuge tube, Add 10.0 mL of the Phosphorous spiking solution. Adjust the pH to 3.0 with 6N acetic acid and allow the suspension to react for 2 hours at 37 °C. Thereafter, centrifuge the suspension at 4000 rpm during 10 min. Transfer the supernatant liquor to a 25 mL volumetric flask and dilute to volume with water. Transfer 1.0 mL of this solution to a 100 mL volumetric flask and dilute to volume with water. Prepare the sample in duplicate. Apply the molybdenum blue method to Phosphorous standards solutions and Test solutions.
- the concentration of iron after the reaction and before the desalinization was 1 8%w/w (g Fe per g of suspension determined by complexometric titration).
- Second decantation The reaction mixture was settled during 12 hours and 400 L of supernatant were being removed. 400 L of deionized water were added to the reactor and the reaction mixture was stirred for 15 minutes at 10-25°C (30 rpm). Then stirring was stopped.
- Third decantation The reaction mixture was settled during 17 hours and 660 L of supernatant were being removed. 660 L of deionized water were added to the reactor and the reaction mixture was stirred for 15 minutes at 10-25°C (30 rpm). Then stirring was stopped.
- the process of desalinisation ended after 6 days.
- To the reaction mixture (632,75 kg, 4.3% of an iron content, determined by complexometric titration) were added 43,6 Kg of potato starch and 43,8 Kg of sucrose.
- An aliquot of the reaction mixture was concentrated to 35°C in a rotary evaporator and dried at 35°C under high vacuum.23.2 g of powder with iron content 20.94% (determined by complexometric titration) was obtained.
- Phosphate binding capacity was determined (by spectrophotometric analysis); 0.22 mgP/mgFe.
- the rest of the batch was dried by spray-drying (146.34 Kg of Sucroferric oxy-hydroxide was obtained).
- the suspension was concentrated to 35°C in a rotary evaporator and dried at 35°C under high vacuum. 19.48 g of powder with iron content 16.6% (determined by complexometric titration) was obtained. Phosphate binding capacity was determined (by spectrophotometric analysis); 0.19 mgP/mgFe.
- comparative Example 1 shows that when the process disclosed in the prior art (cf. Example 1 of US6174442B1 ) is carried out at industrial scale (Batch: 150 Kg), a long time is required to carry out the decantations.
- Comparative Example 2 shows that in conditions of prolonged stirring the product degrades. Therefore, it is unexpected that a dynamic process such as the tangential filtration used in the present invention where the mixture is continuously stirred could work since it would be expected that the product suffered degradation.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18382570 | 2018-07-30 | ||
PCT/EP2019/070384 WO2020025552A1 (en) | 2018-07-30 | 2019-07-29 | Process for preparing an adsorbent for phosphate in aqueous medium |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3829761A1 true EP3829761A1 (de) | 2021-06-09 |
Family
ID=63207695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19742785.9A Withdrawn EP3829761A1 (de) | 2018-07-30 | 2019-07-29 | Verfahren zur herstellung eines adsorbens für phosphat in wässrigem medium |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP3829761A1 (de) |
WO (1) | WO2020025552A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3932535A1 (de) | 2020-07-01 | 2022-01-05 | Vifor Fresenius Medical Care Renal Pharma, Ltd. | Verfahren zur herstellung von durch kohlenhydrate und/oder huminsäure stabilisierten mehrkernigen eisenverbindungen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4970079A (en) | 1989-06-05 | 1990-11-13 | Purdue Research Foundation | Method and composition of oxy-iron compounds for treatment of hyperphosphatemia |
DE19547356A1 (de) | 1995-12-19 | 1997-06-26 | Vifor Int Ag | Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung |
ES2526171T3 (es) * | 2006-12-14 | 2015-01-07 | Novartis Ag | Adsorbente de fosfato a base de hierro (III)-carbohidratos |
TWI468167B (zh) | 2007-11-16 | 2015-01-11 | 威佛(國際)股份有限公司 | 藥學組成物 |
-
2019
- 2019-07-29 WO PCT/EP2019/070384 patent/WO2020025552A1/en unknown
- 2019-07-29 EP EP19742785.9A patent/EP3829761A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2020025552A1 (en) | 2020-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8733559B2 (en) | Zirconium phosphate particles having improved adsorption capacity and method of synthesizing the same | |
JP5814336B2 (ja) | リン酸ジルコニウム粒子の合成法 | |
JP4159355B2 (ja) | 炭酸ナトリウムジルコニウムおよび塩基性炭酸ジルコニウム並びにそれらの製造方法 | |
US4761186A (en) | Method of purifying starches and products produced therefrom | |
US20040191162A1 (en) | Method for processing a zirconium oxide composition in crystalline form | |
WO2020137756A1 (ja) | 血液浄化デバイスと血液成分調整器を備えた体外血液循環システム | |
CN115297953B (zh) | 用于改进尿素捕获的包含吸附剂颗粒的多孔膜 | |
EP3829761A1 (de) | Verfahren zur herstellung eines adsorbens für phosphat in wässrigem medium | |
DE202020101647U1 (de) | Vorrichtung zur Blutreinigung | |
CN111918683A (zh) | 血液净化器及其制法 | |
EP3887034B1 (de) | Verfahren und zusammensetzung zur entfernung von uremischen toxinen | |
JPS614529A (ja) | リン酸イオンの吸着剤 | |
JP6682568B2 (ja) | 血液浄化器及びその製法 | |
US20230174568A1 (en) | Manufacturing Method for Polynuclear Iron Compounds Stabilized by Carbohydrates and/or Humic Acid | |
CN106378011A (zh) | 一种含聚苯乙烯磺酸钠的吸附超滤膜及制备方法 | |
JP4378529B2 (ja) | 生体物質吸着剤及びその製造方法 | |
DE202020101650U1 (de) | Vorrichtung zur Blutreinigung | |
WO2024202383A1 (ja) | 水溶性たんぱく質の濃縮方法、及び水溶性たんぱく質の回収処理方法 | |
CN116710160A (zh) | 吸附材料及其制造方法、吸附片、分离膜和人工透析设备 | |
CN113631257B (zh) | 血液净化器及其制法 | |
Guerreiro et al. | Membranes of cellulose acetate-silica/metal organic framework for the removal of uremic toxins | |
JPS58175565A (ja) | 血漿処理装置 | |
JPH04139263A (ja) | 水溶性染料の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210115 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210921 |